Job search dilemmas
|
| Post date: 2020-08-13 02:01:24 |
| Views: 167 |
I don't feel that secure at my current job, and it looks like I'm about to be offered a new job... at a 17k pay cut. Also some yellow flags? I shouldn't take it, right? Or should I?
Oookay. I am super miserable at my current toxic job, and I also think I am likely to be laid off in September when PPP ends-- but I'm not sure (probably dependent on some funding coming through via a public school department which looks likely but obviously isn't the most sure thing right now).
I'm currently WFH and I don't have to deal with my boss too much, so that's actually been great for my work stress level-- but it's hard to have anxiety about job security and feeling at loose ends right now.
I have been job hunting since March, gone on 5 interviews so far. I currently make $57k, and would like to make at least $50k if I need to take a pay cut. I have enough savings that I would be able to weather over a year of unemployment.
It looks like I'm about to be offered a job with a $40k salary and I'm strongly considering withdrawing from the process/turning it down. The work itself sounds interesting, but beyond the pay not being what I want, there are some other cons:
-The funding is only guaranteed for a year.
-I didn't really like my immediate manager in the interview, I felt like he was condescending and we just didn't "click."
-There are a number of negative reviews on Glassdoor.
-I would need to work in person in a large office instead of WFH, so potential exposure to COVID.
-I was called in for an interview with less than 24 hours notice and then they called me looking for a new reference after playing phone tag with one of my references for only 24 hours, on a state holiday, a week and a half after my interview. Which just seems kind of pushy/indicative of a hurry up and wait culture?
My gut is telling me I should pass on this one. What do y'all think? |
| Please click Here to read the full story. |
| |
| Other Top and Latest Questions: |
Novo Nordisk moves next-gen drug amycretin to late-stage diabetes trial after promising data
|
Alibaba shares rise as AI drives 34% cloud sales jump
|
Best Buy hikes sales forecast as shoppers upgrade tech, splurge on devices
|
Here are Tuesday's biggest analyst calls: Nvidia, Apple, Tesla, Microsoft, Oracle, Live Nation, Coinbase & more
|
New Jersey deli fraudsters fail to pay millions of dollars in restitution, judge says
|
Michael Burry's next 'Big Short': An inside look at his analysis showing AI is a bubble
|
Musk's xAI to close $15 billion funding round in December: sources
|
Bessent says there's a 'very good chance' Trump names new Fed chair before Christmas
|
CNBC's Official NHL Team Valuations 2025: Here's how the 32 franchises stack up
|
Ukraine reportedly agrees to U.S.-brokered peace proposal
|